The Patent Finder

Treatment for Multiple Sclerosis

Biogen Ma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 15/527,252, filed May 16, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,399,514Treatment for Multiple Sclerosis
In force
 · High confidence
Biogen Ma Inc.In force
High confidence
US 10,399,924Deuterium Substituted Fumarate Derivatives
In force
 · High confidence
Biogen Ma Inc.In force
High confidence
US 10,172,794Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
In force
 · High confidence
Biogen Ma Inc.In force
High confidence
US 10,391,160Dimethyl Fumarate and Vaccination Regimens
In force
 · High confidence
Biogen Ma Inc.In force
High confidence
US 10,959,972Methods of Treating Multiple Sclerosis
In force
 · Medium confidence
Biogen Ma Inc.In force
Medium confidence
US 11,007,166Methods of Treating Multiple Sclerosis
In force
 · Medium confidence
Biogen Ma Inc.In force
Medium confidence
US 11,007,167Methods of Treating Multiple Sclerosis
In force
 · Medium confidence
Biogen Ma Inc.In force
Medium confidence
US 11,129,806Methods of Treating Multiple Sclerosis
In force
 · Medium confidence
Biogen Ma Inc.In force
Medium confidence
US 11,246,850Methods of Treating Multiple Sclerosis
In force
 · High confidence
Biogen Ma Inc.In force
High confidence
US 10,555,993Dimethyl Fumarate and Vaccination Regimens
Lapsed Feb 11, 2024 on the fee record
Medium confidence
Biogen Ma Inc.Lapsed Feb 11, 2024 on the fee record
Medium confidence
41 more patents in this group · Pro
10 of 51 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 51, including 4 expired and 1 expiring within the 18 months from Nov 18, 2026.
Upgrade to Pro
9 of these are in force and held by Biogen Ma Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited